NICE recommends Santen’s Roclanda to treat glaucoma and ocular hypertension
Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK
Read More
Tag: Roclanda
Glaucoma therapy Roclanda launched by Santen
By combining both netarsudil and latanoprost treatment, Roclanda reduces intraocular pressure
Read More
Six new medicines leap towards EU approval
The recommendations include new treatments for cancer and intraocular pressure and prevention of uncomplicated flu.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
